eXoZymes is redefining how complex molecules are discovered, manufactured, and commercialized. Our AI-enhanced, cell-free biomanufacturing platform turns rare, unscalable, or economically inaccessible chemistry into predictable, high-purity production processes. By embedding manufacturability directly into discovery, eXoZymes collapses development timelines, lowers capital intensity, and unlocks multiple commercialization paths. The result is a scalable platform with durable IP, capital-light growth, and asymmetric upside across pharmaceutical, wellness, and industrial markets. Out team of scientists, engineers, and other professionals have decades of experience in the bioindustrial space engineering enzymes, enzyme pathways, and bringing bio-based products to market.